- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 260983, 13 pages
CD73 Is Critical for the Resolution of Murine Colonic Inflammation
1Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, C5 149 VMC, Ithaca, NY 14853, USA
2Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Received 14 May 2012; Revised 7 July 2012; Accepted 11 July 2012
Academic Editor: Linda F. Thompson
Copyright © 2012 Margaret S. Bynoe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. L. Lakatos and L. S. Kiss, “Is the disease course predictable in inflammatory bowel diseases?” World Journal of Gastroenterology, vol. 16, no. 21, pp. 2591–2599, 2010.
- Y. R. Mahida, “Microbial-gut interactions in health and disease. Epithelial cell responses,” Best Practice & Research Clinical Gastroenterology, vol. 18, no. 2, pp. 241–253, 2004.
- Y. R. Mahida and V. E. Rolfe, “Host-bacterial interactions in inflammatory bowel disease,” Clinical Science, vol. 107, no. 4, pp. 331–341, 2004.
- P. Munkholm, E. Langholz, D. Hollander et al., “Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives,” Gut, vol. 35, no. 1, pp. 68–72, 1994.
- B. Sonier, C. Patrick, P. Ajjikuttira, and F. W. Scott, “Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity,” International Reviews of Immunology, vol. 28, no. 6, pp. 414–445, 2009.
- B. Newman, M. S. Silverberg, X. Gu et al., “CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease,” American Journal of Gastroenterology, vol. 99, no. 2, pp. 306–315, 2004.
- S. R. Brant and Y. Y. Shugart, “Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field,” Inflammatory Bowel Diseases, vol. 10, no. 3, pp. 300–311, 2004.
- J. R. Turner, “Intestinal mucosal barrier function in health and disease,” Nature Reviews Immunology, vol. 9, no. 11, pp. 799–809, 2009.
- I. Bjarnason, A. MacPherson, and D. Hollander, “Intestinal permeability: an overview,” Gastroenterology, vol. 108, no. 5, pp. 1566–1581, 1995.
- D. J. Friedman, B. M. Künzli, Y. I. A-Rahim et al., “CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 39, pp. 16788–16793, 2009.
- N. A. Louis, A. M. Robinson, C. F. MacManus, J. Karhausen, M. Scully, and S. P. Colgan, “Control of IFN-αA by CD73: implications for mucosal inflammation,” Journal of Immunology, vol. 180, no. 6, pp. 4246–4255, 2008.
- Z. Selmeczy, B. Csóka, P. Pacher, E. S. Vizi, and G. Haskó, “The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice,” Inflammation Research, vol. 56, no. 5, pp. 204–209, 2007.
- C. M. Cruz, A. Rinna, H. J. Forman, A. L. M. Ventura, P. M. Persechini, and D. M. Ojcius, “ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages,” The Journal of Biological Chemistry, vol. 282, no. 5, pp. 2871–2879, 2007.
- G. Haskó, J. Linden, B. Cronstein, and P. Pacher, “Adenosine receptors: therapeutic aspects for inflammatory and immune diseases,” Nature Reviews Drug Discovery, vol. 7, no. 9, pp. 759–770, 2008.
- L. Airas, J. Niemelä, M. Salmi, T. Puurunen, D. J. Smith, and S. Jalkanen, “Differential regulation and function of CD73, a glycosyl- phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells,” Journal of Cell Biology, vol. 136, no. 2, pp. 421–431, 1997.
- L. Antonioli, M. Fornai, R. Colucci et al., “Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases,” Inflammatory Bowel Diseases, vol. 14, no. 4, pp. 566–574, 2008.
- S. Gessi, S. Merighi, K. Varani et al., “Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine subtype,” Journal of Cellular Physiology, vol. 211, no. 3, pp. 826–836, 2007.
- M. L. Hart, M. Henn, D. Köhler et al., “Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury,” The FASEB Journal, vol. 22, no. 8, pp. 2784–2797, 2008.
- K. Synnestvedt, G. T. Furuta, K. M. Comerford et al., “Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia,” Journal of Clinical Investigation, vol. 110, no. 7, pp. 993–1002, 2002.
- S. Deaglio, K. M. Dwyer, W. Gao et al., “Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression,” Journal of Experimental Medicine, vol. 204, no. 6, pp. 1257–1265, 2007.
- M. Odashima, G. Bamias, J. Rivera-Nieves et al., “Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease,” Gastroenterology, vol. 129, no. 1, pp. 26–33, 2005.
- B. Siegmund, F. Rieder, S. Albrich et al., “Adenosine kinase inhibitor GP515 improves experimental colitis in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 296, no. 1, pp. 99–105, 2001.
- L. F. Thompson, H. K. Eltzschig, J. C. Ibla et al., “Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia,” Journal of Experimental Medicine, vol. 200, no. 11, pp. 1395–1405, 2004.
- C. G. Whittem, A. D. Williams, and C. S. Williams, “Murine Colitis modeling using Dextran Sulfate Sodium (DSS),” JoVE: Journal of Visualized Experiments, no. 35, article e1652, 2010.
- Y. Obata, D. Takahashi, M. Ebisawa et al., “Epithelial cell-intrinsic Notch signaling plays an essential role in the maintenance of gut immune homeostasis,” Journal of Immunology, vol. 188, no. 5, pp. 2427–2436, 2012.
- J. H. Mills, L. Alabanza, B. B. Weksler, P. O. Couraud, I. A. Romero, and M. S. Bynoe, “Human brain endothelial cells are responsive to adenosine receptor activation,” Purinergic Signalling, vol. 7, no. 2, pp. 265–273, 2011.
- F. Powrie, “T cells in inflammatory bowel disease: protective and pathogenic roles,” Immunity, vol. 3, no. 2, pp. 171–174, 1995.
- F. Powrie, M. W. Leach, S. Mauze, L. B. Caddle, and R. L. Coffman, “Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice,” International Immunology, vol. 5, no. 11, pp. 1461–1471, 1993.
- J. H. Mills, L. F. Thompson, C. Mueller et al., “CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 27, pp. 9325–9330, 2008.
- S. P. Colgan, H. K. Eltzschig, T. Eckle, and L. F. Thompson, “Physiological roles for ecto-5′-nucleotidase (CD73),” Purinergic Signalling, vol. 2, no. 2, pp. 351–360, 2006.
- A. I. Ivanov, A. Nusrat, and C. A. Parkos, “The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption,” Novartis Foundation Symposium, vol. 263, pp. 115–124, 2004.
- G. Rogler and T. Andus, “Cytokines in inflammatory bowel disease,” World Journal of Surgery, vol. 22, no. 4, pp. 382–389, 1998.
- K. Kimura, S. Teranishi, and T. Nishida, “Interleukin-1β-induced disruption of barrier function in cultured human corneal epithelial cells,” Investigative Ophthalmology and Visual Science, vol. 50, no. 2, pp. 597–603, 2009.
- A. A. Beg, T. S. Finco, P. V. Nantermet, and A. S. Baldwin Jr., “Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation,” Molecular and Cellular Biology, vol. 13, no. 6, pp. 3301–3310, 1993.
- A. Kaser, S. Zeissig, and R. S. Blumberg, “Inflammatory bowel disease,” Annual Review of Immunology, vol. 28, pp. 573–621, 2010.
- S. Morello, K. Ito, S. Yamamura et al., “IL-1β and TNF-α regulation of the adenosine receptor (A 2A) expression: differential requirement for NF-κB binding to the proximal promoter,” Journal of Immunology, vol. 177, no. 10, pp. 7173–7183, 2006.
- D. R. Clayburgh, L. Shen, and J. R. Turner, “A porous defense: the leaky epithelial barrier in intestinal disease,” Laboratory Investigation, vol. 84, no. 3, pp. 282–291, 2004.
- M. A. McGuckin, R. Eri, L. A. Simms, T. H. J. Florin, and G. Radford-Smith, “Intestinal barrier dysfunction in inflammatory bowel diseases,” Inflammatory Bowel Diseases, vol. 15, no. 1, pp. 100–113, 2009.
- M. G. Laukoetter, P. Nava, W. Y. Lee et al., “JAM-A regulates permeability and inflammation in the intestine in vivo,” Journal of Experimental Medicine, vol. 204, no. 13, pp. 3067–3076, 2007.
- S. Nell, S. Suerbaum, and C. Josenhans, “The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models,” Nature Reviews Microbiology, vol. 8, no. 8, pp. 564–577, 2010.
- M. T. Abreu, “Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function,” Nature Reviews Immunology, vol. 10, no. 2, pp. 131–143, 2010.
- J. H. Niess, “Role of gut-resident dendritic cells in inflammatory bowel disease,” Expert Review of Clinical Immunology, vol. 5, no. 4, pp. 451–461, 2009.
- P. N. Fries and P. J. Griebel, “Mucosal dendritic cell diversity in the gastrointestinal tract,” Cell and Tissue Research, vol. 343, no. 1, pp. 33–41, 2011.
- M. Mavris and P. Sansonetti, “Microbial-gut interactions in health and disease. Epithelial cell responses,” Best Practice & Research Clinical Gastroenterology, vol. 18, no. 2, pp. 373–386, 2004.
- M. Rescigno, “The intestinal epithelial barrier in the control of homeostasis and immunity,” Trends in Immunology, vol. 32, no. 6, pp. 256–264, 2011.
- J. M. Wells, O. Rossia, M. Meijerink, and P. Van Baarlen, “Epithelial crosstalk at the microbiota-mucosal interface,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 4607–4614, 2011.
- H. B. Jijon, J. Walker, F. Hoentjen et al., “Adenosine is a negative regulator of NF-κB and MAPK signaling in human intestinal epithelial cells,” Cellular Immunology, vol. 237, no. 2, pp. 86–95, 2005.
- J. Lee, J. H. Mo, K. Katakura et al., “Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells,” Nature Cell Biology, vol. 8, no. 12, pp. 1327–1336, 2006.